Nebenwirkungen · NovoMix
NovoMix 30 Penfill 100 units/ml suspension for injection in cartridge NovoMix 30 FlexPen 100 units/ml suspension for injection in pre-filled pen · Abschnitt 4.8 · PDF-Seite 8
HOS-091233 · Präparat HOS-084239
Hypoglycaemia: The most frequently reported adverse reaction is hypoglycaemia. It may occur if the insulin dose is too high in relation to the insulin requirement. Severe hypoglycaemia may lead to unconsciousness and/or convulsions and may result in temporary or permanent impairment of brain function or even death. The symptoms of hypoglycaemia usually occur suddenly. They may include cold sweats, cool pale skin, fatigue, nervousness or tremor, anxiousness, unusual tiredness or weakness, confusion, difficulty in concentrating, drowsiness, excessive hunger, vision changes, headache, nausea and palpitation.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-08-29T13:39:00Z · SHA-256 a9b6af8deb9323a5e47af7edaf7c4d716632fe6a60c5ba5c930ab9830ed01a03 · Passage 990a337c2e6abf28082092cefd6c7641205798436857e54dca431269ce76727a · Zeichen 2818–3430 im Abschnitt